Synonyms: compound 3b [2] | TH-302
Compound class:
Synthetic organic
Comment: Evofosfamide is a hypoxia-activated prodrug being investigated as an antineoplastic therapeutic (compound 3b in [2]). This compound is related to ifosfamide. Being developed by Threshold Pharmaceuticals.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
2-bromo-N-[(2-bromoethylamino)-[(3-methyl-2-nitroimidazol-4-yl)methoxy]phosphoryl]ethanamine |
International Nonproprietary Names ![]() |
|
INN number | INN |
9811 | evofosfamide |
Synonyms ![]() |
|
compound 3b [2] | TH-302 |
Database Links ![]() |
|
CAS Registry No. | 918633-87-1 (source: PubChem) |
ChEMBL Ligand | CHEMBL260046 |
GtoPdb PubChem SID | 252166895 |
PubChem CID | 11984561 |
Search Google for chemical match using the InChIKey | UGJWRPJDTDGERK-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | UGJWRPJDTDGERK |
Search PubMed clinical trials | evofosfamide |
Search PubMed titles | evofosfamide |
Search PubMed titles/abstracts | evofosfamide |
UniChem Compound Search for chemical match using the InChIKey | UGJWRPJDTDGERK-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | UGJWRPJDTDGERK-UHFFFAOYSA-N |